Conversational AI in Tactical Casualty Care: Baseline GPT-4o Improves Combat Medic Decision-Making

NCT ID: NCT06796036

Last Updated: 2025-05-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

42 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-02-02

Study Completion Date

2025-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the project is to investigate whether the integration of artificial intelligence (AI) support, specifically through the GPT-4 model, enhances the decision-making processes of military medical first responders within the framework of Tactical Combat Casualty Care (TCCC). The study focuses on AI's ability to assist in ventilator settings for injured individuals in combat scenarios, emphasizing improved accuracy and decision-making speed. The project tests the hypothesis that the use of AI can positively impact outcomes without compromising the autonomy of first responders. The results have the potential to optimize patient care in challenging conditions and contribute to the advancement of combat medicine.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study investigates the potential of conversational artificial intelligence (AI), specifically GPT-4, to enhance clinical decision-making in Tactical Combat Casualty Care (TCCC) scenarios. The primary objective is to evaluate whether AI support improves the accuracy and efficiency of ventilator management decisions for combat medics in high-pressure environments without compromising their autonomy.

A prospective, randomized, within-subject study design will be employed. Thirty combat medics from the Czech Armed Forces will participate. Each participant will complete 10 simulated TCCC scenarios: five with AI assistance and five without. Scenarios will be matched for complexity and randomized to control for order effects. Participants will use ChatGPT on handheld devices to simulate real-time AI-assisted decision-making.

In scenarios involving AI assistance, medics will query GPT-4 for support in optimizing mechanical ventilator settings based on patient data, including blood gas results, vital signs, and ventilator parameters.

The primary outcome is the accuracy of ventilator settings as categorized into "excellent," "acceptable," or "failing" based on predefined TCCC standards. Secondary outcomes include decision-making speed and participants' perception of AI's utility, measured through post-scenario surveys.

The findings aim to determine the feasibility of integrating large language models (LLMs) into combat medical care to optimize patient outcomes and support medics under combat conditions. The study seeks to advance the understanding of AI's role in military medicine, providing a foundation for future deployment of fine-tuned AI solutions in TCCC and other critical care scenarios.

This study offers a proof-of-concept evaluation of LLM applications in combat casualty care, with the potential to improve decision-making and inform the development of specialized AI tools for military use.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Artificial Intelligence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Crossover assignment (each participant acts as their own control in scenarios with and without artificial intelligence)
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Combat Medic Decision-Making with and without AI Assistance

All participants will complete 10 Tactical Combat Casualty Care scenarios: 5 with AI assistance using GPT-4 for ventilator management and 5 without AI assistance. The crossover design ensures each participant experiences both conditions.

Group Type EXPERIMENTAL

Combat Medic Decision-Making with and without artificial intelligence assistance

Intervention Type OTHER

Participants will complete 10 simulated Tactical Combat Casualty Care (TCCC) scenarios, with 5 scenarios conducted using AI assistance (GPT-4) and 5 without AI. In AI-assisted scenarios, participants will use GPT-4 to query and optimize ventilator settings based on patient data, while non-AI scenarios rely solely on their clinical judgment.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Combat Medic Decision-Making with and without artificial intelligence assistance

Participants will complete 10 simulated Tactical Combat Casualty Care (TCCC) scenarios, with 5 scenarios conducted using AI assistance (GPT-4) and 5 without AI. In AI-assisted scenarios, participants will use GPT-4 to query and optimize ventilator settings based on patient data, while non-AI scenarios rely solely on their clinical judgment.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Combat medics actively serving in the Czech Armed Forces
* Completion of standardized Tactical Combat Casualty Care training modules and e-learning on ventilator settings and blood gas interpretation
* Successful passing of pre-tests to ensure a uniform baseline knowledge level.
* Willingness to participate and provide informed consent.
* Availability to complete the full study protocol, including 10 simulated scenarios.

Exclusion Criteria

* Failure to pass the pre-tests or complete TCCC and ventilator management training
* Prior advanced training or professional certification in critical care or mechanical ventilation that could bias results
* Refusal to provide informed consent or inability to commit to the study schedule
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Czech Technical University in Prague

OTHER

Sponsor Role collaborator

Charles University, Czech Republic

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Michal Soták

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michal Soták, M.D., Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Charles University, Czech Republic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Military University Hospital Prague

Prague, , Czechia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Czechia

References

Explore related publications, articles, or registry entries linked to this study.

Nemeth C, Amos-Binks A, Rule G, Laufersweiler D, Keeney N, Flint I, Pinevich Y, Herasevich V. TCCC Decision Support With Machine Learning Prediction of Hemorrhage Risk, Shock Probability. Mil Med. 2023 Nov 8;188(Suppl 6):659-665. doi: 10.1093/milmed/usad298.

Reference Type RESULT
PMID: 37948287 (View on PubMed)

Preiksaitis C, Ashenburg N, Bunney G, Chu A, Kabeer R, Riley F, Ribeira R, Rose C. The Role of Large Language Models in Transforming Emergency Medicine: Scoping Review. JMIR Med Inform. 2024 May 10;12:e53787. doi: 10.2196/53787.

Reference Type RESULT
PMID: 38728687 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FieldAI

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.